A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Letrozole|DRUG: Anastrozole|DRUG: Vinorelbine
Sponsor: Centre Hospitalier Universitaire de Besancon
Collaborators: Pierre Fabre Medicament